Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.

MLA

Onishi, Natsuko, et al. “Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.” Tomography (Ann Arbor, Mich.), vol. 6, no. 2, June 2020, pp. 77–85. EBSCOhost, https://doi.org/10.18383/j.tom.2020.00006.

APA

Onishi, N., Li, W., Gibbs, J., Wilmes, L. J., Nguyen, A., Jones, E. F., Arasu, V., Kornak, J., Joe, B. N., Esserman, L. J., Newitt, D. C., & Hylton, N. M. (2020). Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography (Ann Arbor, Mich.), 6(2), 77–85. https://doi.org/10.18383/j.tom.2020.00006

Chicago

Onishi, Natsuko, Wen Li, Jessica Gibbs, Lisa J Wilmes, Alex Nguyen, Ella F Jones, Vignesh Arasu, et al. 2020. “Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.” Tomography (Ann Arbor, Mich.) 6 (2): 77–85. doi:10.18383/j.tom.2020.00006.